EAU Edu Platform on functional urology
Home
Articles
Editorial
Videos
Webcasts
Education
E-courses
Webinars
Male LUTS Curriculum
Guidelines
Events
Home
Articles
Terug
Editorial
Videos
Webcasts
Education
Terug
E-courses
Webinars
Male LUTS Curriculum
Guidelines
Events
Upcoming event
Masterclass on Lasers in urology
Home
/
Webcasts
Back
MaleLUTS
Nocturia
Bedwetting
EAU 2023
EAU 2022
EAU21
ESU Masterclasses
EAU 19
ESPU 14
ICS 2013
ICI-RS 2013
EAU17
Filter
Tags
5-α reductase inhibitors
,
5α-Reductase inhibitors
,
Aanticoagulants
,
Abiraterone
,
Actigraphy
,
Active surveillance
,
Adenotonsillectomy
,
Adjuvant
,
Adolescent
,
ADT
,
Advanced prostate cancer
,
Alkaline phosphatase
,
Alternative splicing
,
Androgen
,
Androgen antagonists
,
Androgen deprivation therapy
,
Androgen pathway blockade
,
Androgen receptor inhibitor
,
Antegrade ejaculation
,
Antiandrogens
,
Anticancer agents
,
Antidiuretic
,
Antimuscarinics
,
Apnea
,
Aquablation
,
ARCHES
,
Arousal
,
Article of the Month
,
ASCO GU21
,
ASCO GU22
,
ASCO21
,
AUA21
,
AUA24
,
Avanafil
,
BCG
,
BCG therapy
,
BCG-unresponsive disease
,
Benign Prostatic Diseases
,
BHC80
,
BHP
,
Biochemical recurrence
,
Biomarkers
,
Biopsy
,
bipolar TURO
,
Bisphosphonates
,
Bladder
,
Bladder capacity
,
Bladder injury
,
Bladder neoplasms
,
Bladder outlet obstruction
,
Bladder trauma
,
Bladder-sparing therapy
,
Bladder-sparing trimodality
,
BNC
,
Bone metastases
,
BOO
,
BOOI
,
BPD
,
BPE
,
BPH
,
BPO
,
BRCA1
,
BRCA2
,
Cabozantinib
,
Carcinoma
,
Castrate-resistanter
,
Castration-resistant
,
Chemoradiotherapy
,
Chemotherapy
,
Chronic bacterial prostatitis
,
Chronic kidney disease
,
Circadian rhythms
,
Clinical pathways
,
Clinical practice guidelines
,
Clinical staging
,
Clinical trial
,
Clinical trials
,
Cohort study
,
Collaborative care
,
Comorbidity
,
Corticotropin-releasing factor
,
COVID-19
,
CP/CPPS
,
CPPS
,
Cryosurgery
,
cSP
,
Curriculum
,
Cystectomy
,
Deferred treatment
,
Depression
,
Desmopressin
,
Detrusor
,
Detrusor hypocontractility
,
Detrusor overactivity
,
Diagnosis
,
Dihydrotestosterone
,
Disease progression
,
Docetaxel
,
Drug adherence
,
Drug therapy
,
Dutasteride
,
Early recurrence patterns
,
EAU
,
EAU21
,
EAU22
,
Ejaculation
,
Ejaculation preservation
,
Ejaculatory dysfunction
,
Emission-computed
,
EMUC21
,
EMUC22
,
End-to-side nerve grafting
,
Endoscopic surgery
,
Enuresis
,
Enzalutamide
,
EORTC
,
Epidemiology
,
ERBB2
,
ERCC2
,
Erectile dysfunction
,
Erectile function
,
ERUS22
,
ESMO21
,
ESMO22
,
ESOU Online
,
ESOU21
,
ESOU22
,
ESU Masterclass
,
ESU Masterclasses
,
External beam radiotherapy
,
Fexapotide triflutate
,
Fibrosis
,
Finasteride
,
Focal therapy
,
Fractures
,
Frail patient
,
Frequency volume chart
,
Frozen section
,
Fusion biopsies
,
Gene expression analysis
,
Genomic classifier
,
Genomics
,
GL-XPS
,
Glomerular filtration rate
,
GreenLight laser
,
Guidelines
,
Hematuria
,
Herbal medicines
,
High-risk NMIBC
,
Highlight of the Month
,
HoLEP
,
hormone-sensitive
,
HORRAD
,
HRQL
,
Hypogonadism
,
Hypoxia
,
IC/BPS
,
ICS21
,
Image guided biopsy
,
Imaging
,
IMDC risk model
,
Immune checkpoint
,
Immune checkpoint blockade
,
Immunohistochemistry
,
Immunoregulation
,
Immunotherapy
,
Impaired contractility
,
Incontinence
,
Index lesion
,
Indocyanine green
,
Infection
,
Infertility
,
Inflammation
,
Inflammatory biomarkers
,
Innervation
,
Intensity-modulated radiotherapy
,
Intravesical therapy
,
IPP
,
IPSS
,
iTIND
,
Kidney cancer
,
Laparoscopic radical cystectomy
,
Laparoscopy
,
Laser Bipolar
,
Laser prostatectomy
,
Laser therapy
,
Local radiotherapy
,
Localised
,
Localized
,
Localized prostate cancer
,
LUT
,
LUTS
,
Lymph node excision
,
Lymph node metastases
,
Lymph nodes
,
Lymphadenectomy
,
Major cardiac adverse event
,
Male LUTS
,
Management of Non-Neurogenic LUTS incl. BPO
,
Mapping
,
Mass spectrometry
,
Masterclass
,
Masterclass on BPO
,
Masterclass on Lasers in urology
,
Masterclass on MIBC
,
Masterclass on NMIBC
,
Masterclasses
,
MDV3100
,
Medical therapy
,
Melatonin
,
Membranous urethra
,
Meta analysis
,
Meta regression
,
Metabolic syndrome
,
Metastasectomy
,
Metastasis
,
Metastasized
,
Metastatic
,
Metastatic urothelial cancer
,
MIBC
,
Microbiome
,
Microscopic haematuria
,
Micturition chart
,
Minimally invasive surgical therapy
,
minimally invasive techniques
,
Mirabegron
,
Molecular subtypes
,
Monotherapies
,
Mortality
,
Mortality reduction
,
mp-MRI
,
MRI
,
Multiparametric MRI
,
Multiple sclerosis
,
Muscarinic antagonist
,
Neoadjuvant
,
Neoadjuvant chemotherapy
,
Neoplasm metastasis
,
Neoplasm recurrence
,
Neoplasm staging
,
Nephrectomy
,
Nephron-sparing surgery
,
Nephroureterectomy
,
Nerve sparing
,
Neuro-urology
,
Neuromodulation
,
Neurourology
,
Next-generation sequencing
,
NIBC
,
nitinol
,
Nivolumab
,
Nocturia
,
Nocturia Symposium
,
Nocturia Think Tank
,
Nocturnal enuresis
,
Nocturnal Enuresis and Alarm Treatment
,
Nocturnal Enuresis and Desmopressin
,
Nocturnal Enuresis and Quality of Life
,
Nocturnal polyuria
,
Nocturnal voiding frequency
,
Nomogram
,
Non-visible haematuria
,
Noncastrate
,
Noninvasive
,
Nuclear matrix protein 22
,
NX-1207
,
OAB
,
Obesity
,
Obstructive sleep apnea
,
Obstructive sleep apnea syndrome
,
Oncologic outcomes
,
Online curriculum
,
Open radical cystectomy
,
Optical coherence
,
Orchiectomy
,
Overactive bladder
,
Overall survival
,
Overdiagnosis
,
p53
,
Paediatric Urology
,
Parental punishment
,
Partial nephrectomy
,
Pathogenesis
,
Pathophysiology
,
Patient information
,
Patient satisfaction
,
Patient-reported outcome
,
PCa21
,
PD-L1
,
Pembrolizumab
,
Penile rehabilitation
,
Permixon
,
PET
,
PET/CT
,
Pharmacology
,
Phenotypically directed multimodal management
,
Phosphodiesterase type 5 inhibitor
,
Phosphodiesterase type 5 inhibitors
,
Phytotherapy
,
Placebo effect
,
Plasmakinetic enucleation
,
PLND
,
Positron emission tomography
,
Postoperative complications
,
Potential risk factors
,
POUT trial
,
Precision medicine
,
Pretreatment risk stratification
,
Pretreatment tables
,
Prevention & control
,
Primary tumor treatment
,
Prognosis
,
Prognostic model
,
Prognostication
,
Prospective study
,
Prostasomes
,
Prostate
,
Prostate arterial embolisation
,
Prostate screening
,
Prostate surgery
,
Prostate-specific antigen
,
Prostate-specific membrane antigen
,
Prostatectomy
,
Prostatic
,
Prostatic arterial embolization
,
Prostatic artery embolization
,
Prostatic hyperplasia
,
Prostatic neoplasms
,
Prostatitis
,
ProtecT trial
,
Proteomics
,
PSA
,
PSA flare
,
PSA kinetics
,
PSA screening
,
PSMA PET/CT
,
PTEN
,
PUL
,
QoL
,
Quality of life
,
Radiation therapy
,
Radical cystectomy
,
Radical nephrectomy
,
Radical prostatectomy
,
Radical surgery
,
Radio-chemotherapy
,
Randomized controlled trial
,
Randomized prospective trial
,
Randomized trial
,
Randomized trials
,
Rapid metastasis
,
RARC
,
RASP
,
Rb
,
RB1
,
Receptors
,
Recurrence
,
Remission
,
Renal cancer
,
Renal cell
,
Renal cell carcinoma
,
Renal cryoablation
,
Renal function
,
Renal function profile
,
Renorrhaphy
,
Retrograde ejaculation
,
Risk stratification
,
RNA splicing
,
Robotic
,
Robotic prostatectomy
,
Robotic radical cystectomy
,
Robotic surgery
,
Robotic Urology
,
Robotics
,
Salivary alpha-amylase
,
Salvage therapy
,
Screening
,
Sentinel lymph node
,
Serenoa repens
,
Sexual Dysfunction
,
Sexual dysfunctions
,
Sexual quality of life
,
Sildenafil
,
Simple prostatectomy
,
Sleep quality
,
Sleep-disordered breathing
,
Sodium diuresis
,
Solifenacin
,
SREs
,
SRRM4
,
STAMPEDE
,
Stem cells
,
Stereotactic body radiotherapy
,
Surgery
,
Surgical intervention
,
Surgical margins
,
Surgical video
,
surgical videos
,
Survival outcome
,
Suture
,
Sympathetic nervous activity
,
Systematic biopsy
,
Systematic review
,
Tadalafil
,
Tamsulosin
,
Targeted Biopsy
,
Targeted therapies
,
Telomerase
,
Testosterone
,
ThuLEP
,
TITAN
,
TmLRP
,
Tolterodine
,
Tomography
,
TP53
,
Transcriptome
,
Transitional cell
,
Transitional cell carcinoma
,
Transperineal template biopsy
,
Treatment response
,
Tregs
,
Tumor suppressor genes
,
TUR syndrome
,
TURis
,
TURP
,
Ultrasensitive PSA
,
Ultrasonography
,
Underactive bladder
,
urethral implantable device
,
Urethral injury
,
Urethral trauma
,
Urinary bladder neoplasms
,
Urinary diversion
,
Urinary incontinence
,
Urinary Incontinence in Adults
,
Urinary nerve growth factor
,
Urinary sphincter
,
Urinary tract infection
,
Urodynamic
,
Urodynamics
,
Urodynamics techniques
,
Urolift
,
Urological surgery
,
Urothelial cancer
,
Urothelium
,
UROwebinar
,
UTUC
,
Vardenafil
,
Voiding
,
Voiding diary
,
Voiding dysfunction
,
Water diuresis
,
WCRF/AICR CUP
,
Webinar
,
Wnt
,
Zoledronic acid
,
α-Adrenergic blocker
,
α-Adrenoceptor antagonists
,
α-Blocker
,
α-blockers
,
α1-Blockers
Show all
Why are pressure-flow studies not mandated for all men before BPO surgery?
Watch now
Video: Totally-en-bloc low-power TFL enucleation of the prostate
Watch now
Lasers for BPO: which technique for which prostate?
Watch now
Aquablation
Watch now
Bipolar en-bloc enucleation of the prostate
Watch now
Laparoscopic Robotic adenomectomy
Watch now
Which surgery for which prostate and why: Prostatectomy, TURP/laser and enucleation
Watch now
Lasers for BPO: Different techniques for different prostates
Watch now
Two-year outcomes after aquablation compared to TURP: Results from a blinded randomized trial
Watch now
A prospective, randomizised clinical trial comparing holmium laser enucleation versus photoselective vaporization for day-surgery to treat benign prostatic hyperplasia
Watch now
Management of nocturia
Watch now
Introduction of new techniques in the treatment of BPH: Faith, truth or fake news?
Watch now
Previous
Next